ArticlePharmaceutics2022

A Randomized Placebo-Controlled Phase 2 Study of Gemcitabine and Capecitabine with or without T-ChOS as Adjuvant Therapy in Patients with Resected Pancreatic Cancer (CHIPAC).

Susann Theile et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.